Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Depreciation & Amortization (CF) (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Depreciation & Amortization (CF) for 3 consecutive years, with $237000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) changed N/A to $237000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at $970000.0 for FY2025, N/A changed from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $237000.0 at Adagio Medical Holdings, down from $500000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $500000.0 in Q3 2025, with the low at $100000.0 in Q3 2023.
  • Average Depreciation & Amortization (CF) over 3 years is $260444.4, with a median of $257000.0 recorded in 2024.
  • The sharpest move saw Depreciation & Amortization (CF) skyrocketed 216.0% in 2024, then dropped 22.18% in 2025.
  • Over 3 years, Depreciation & Amortization (CF) stood at $133000.0 in 2023, then soared by 137.59% to $316000.0 in 2024, then decreased by 25.0% to $237000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $237000.0, $500000.0, and $200000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.